Skip to main content

Westby Keith's Form 4 filing

IVERIC bio, Inc. (ISEE) · filed Apr 6, 2022

Accession no.
0001410939-22-000050
Filed
Apr 6, 2022
Trade date
Apr 4-5, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $570.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Westby KeithCIK 0001696429Officer (SVP & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 4, 2022Common StockMOption exerciseAcquired+20,702$1.45+$30,017.9129,830Direct
Apr 4, 2022Common StockSSaleDisposed−20,702$19.00F2−$393,338109,128Direct
Apr 5, 2022Common StockMOption exerciseAcquired+9,298$1.45+$13,482.1118,426Direct
Apr 5, 2022Common StockSSaleDisposed−9,298$19.02F3−$176,847.96109,128Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 4, 2022Common StockMOption exerciseDisposed−20,702$1.45−$30,017.979,298Direct
Apr 5, 2022Common StockMOption exerciseDisposed−9,298$1.45−$13,482.170,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $19.00 to $19.01 per share on April 4, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F3

The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $19.00 to $19.11 per share on April 5, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)